Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

J. Wang, S. V. Liu, H. E. Uronis, C. Wu, D. Mahalingam, A. Spira, L. Carter, X. Hu, G. Weems, H. J. Wilkins, L. R. Duska, K. Kelly

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii404-viii405
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this